XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at Dec. 31, 2020 $ 45,670 $ 214 $ 96,104 $ (50,648)  
Balance (in shares) at Dec. 31, 2020   21,379,000      
Issuance of unrestricted stock   $ 1 (1)    
Issuance of unrestricted stock (in shares)   131,000      
Shares surrendered by employees to pay taxes related to unrestricted stock (54)   (54)    
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares)   (16,000)      
Stock-based compensation expense 197   197    
Net income (loss) (1,448)     (1,448)  
Balance at Mar. 31, 2021 44,365 $ 215 96,246 (52,096)  
Balance (in shares) at Mar. 31, 2021   21,494,000      
Balance at Dec. 31, 2020 45,670 $ 214 96,104 (50,648)  
Balance (in shares) at Dec. 31, 2020   21,379,000      
Net income (loss) (4,569)        
Balance at Sep. 30, 2021 42,149 $ 215 97,151 (55,217)  
Balance (in shares) at Sep. 30, 2021   21,549,000      
Balance at Mar. 31, 2021 44,365 $ 215 96,246 (52,096)  
Balance (in shares) at Mar. 31, 2021   21,494,000      
Issuance of common stock under employee stock purchase plan 25   25    
Issuance of common stock under employee stock purchase plan (in shares)   7,000      
Stock-based compensation expense 439   439    
Net income (loss) (1,542)     (1,542)  
Balance at Jun. 30, 2021 43,287 $ 215 96,710 (53,638)  
Balance (in shares) at Jun. 30, 2021   21,501,000      
Issuance of common stock under employee stock purchase plan (in shares)   48,000      
Stock-based compensation expense 441   441    
Net income (loss) (1,579)     (1,579)  
Balance at Sep. 30, 2021 42,149 $ 215 97,151 (55,217)  
Balance (in shares) at Sep. 30, 2021   21,549,000      
Balance at Dec. 31, 2021 $ 41,522 $ 216 97,778 (56,472)  
Balance (in shares) at Dec. 31, 2021 21,613,982 21,614,000      
Issuance of unrestricted stock (in shares)   28,000      
Stock-based compensation expense $ 430   430    
Net income (loss) (1,278)     (1,278)  
Balance at Mar. 31, 2022 40,674 $ 216 98,208 (57,750)  
Balance (in shares) at Mar. 31, 2022   21,642,000      
Balance at Dec. 31, 2021 $ 41,522 $ 216 97,778 (56,472)  
Balance (in shares) at Dec. 31, 2021 21,613,982 21,614,000      
Net income (loss) $ 31        
Balance at Sep. 30, 2022 $ 42,648 $ 217 99,041 (56,440) $ (170)
Balance (in shares) at Sep. 30, 2022 21,686,528 21,687,000      
Balance at Mar. 31, 2022 $ 40,674 $ 216 98,208 (57,750)  
Balance (in shares) at Mar. 31, 2022   21,642,000      
Issuance of common stock under employee stock purchase plan 93 $ 1 92    
Issuance of common stock under employee stock purchase plan (in shares)   40,000      
Stock-based compensation expense 378   378    
Repurchase of common stock (3)   (3)    
Repurchase of common stock (in shares)   (1,000)      
Net income (loss) (1,289)     (1,289)  
Balance at Jun. 30, 2022 39,853 $ 217 98,675 (59,039)  
Balance (in shares) at Jun. 30, 2022   21,681,000      
Issuance of unrestricted stock 3 $ 1 2    
Issuance of unrestricted stock (in shares)   91,000      
Shares surrendered by employees to pay taxes related to unrestricted stock (24)   (24)    
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares)   (10,000)      
Stock-based compensation expense 548   548    
Repurchase of common stock (161) $ (1) (160)    
Repurchase of common stock (in shares)   (75,000)      
Other comprehensive loss (170)       (170)
Net income (loss) 2,599     2,599  
Balance at Sep. 30, 2022 $ 42,648 $ 217 $ 99,041 $ (56,440) $ (170)
Balance (in shares) at Sep. 30, 2022 21,686,528 21,687,000